跳至主要内容
临床试验/DRKS00030699
DRKS00030699已完成Unknown

Evaluation of positive care effects and health economic significance of a patient-centered gait analysis app for use in the home with telehealth monitoring. - ParkinsonGo Pilotstudy

Abteilung für Molekulare Neurologie, Universitätsklinik Erlangen0 个研究点目标入组 68 人开始时间: 2022年11月21日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • •1. idiopathic parkinsonian syndrome (H&Y II-III).
  • •2. UPDRS III > 13 with involvement uEx
  • •3. ability to walk > 10 m without support
  • •4. minimal mental status test (MMST) score = 26.
  • •5. willingness of the study participant to take up therapy measures (e.g., drug therapy, exercise therapy) (already prior to study participation).

排除标准

  • •1. tremor dominant parkinsonian syndrome
  • •2. risk of falling with high injury potential
  • •3. if included, current or planned inpatient stay within the next two weeks
  • •4. severe ON freezing
  • •5. severe internistic/orthopedic/psychological comorbidities

研究者

发起方
Abteilung für Molekulare Neurologie, Universitätsklinik Erlangen

相似试验